Abcellera Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.About ABCL
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.
CEOCarl Lars G. Hansen
CEOCarl Lars G. Hansen
Employees596
Employees596
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded2012
Founded2012
Employees596
Employees596
ABCL Key Statistics
Market cap1.10B
Market cap1.10B
Price-Earnings ratio-6.33
Price-Earnings ratio-6.33
Dividend yield—
Dividend yield—
Average volume4.51M
Average volume4.51M
High today$3.74
High today$3.74
Low today$3.45
Low today$3.45
Open price$3.48
Open price$3.48
Volume3.71M
Volume3.71M
52 Week high$6.52
52 Week high$6.52
52 Week low$1.89
52 Week low$1.89
Stock Snapshot
The current Abcellera Biologics(ABCL) stock price is $3.69, with a market capitalization of 1.1B. The stock trades at a price-to-earnings (P/E) ratio of -6.33.
On 2025-12-05, Abcellera Biologics(ABCL) stock moved within a range of $3.45 to $3.74. With shares now at $3.69, the stock is trading +6.9% above its intraday low and -1.4% below the session's peak.
Trading volume for Abcellera Biologics(ABCL) stock has reached 3.71M, versus its average volume of 4.51M.
Over the past 52 weeks, Abcellera Biologics(ABCL) stock has traded between a high of $6.52 and a low of $1.89.
Over the past 52 weeks, Abcellera Biologics(ABCL) stock has traded between a high of $6.52 and a low of $1.89.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ABCL. This list is generated using Robinhood data, and it’s not a recommendation.